Research publications

Scientific papers about our projects :

Research publications

A chemically-defined plastic scaffold for the xeno-free production of human pluripotent stem cells

A chemically-defined plastic scaffold for the xeno-free production of human pluripotent stem cells

Shimizu E, Iguchi H, Le M N T, Nakamura Y, Kobayashi D, Arai Y, Takakura K, Benno S, Yoshida N, Tsukahara M, Haneda S, Hasegawa K

Scientific Reports volume 12: 2516 doi.org/10.1038/s41598-022-06356-8 (2022)

Research publications

Grafting of iPS cell-derived tenocytes promotes motor function recovery after Achilles tendon rupture

Nakajima T, Nakahata A, Yamada N, Yoshizawa K, Kato TM, Iwasaki M, Zhao C, Kuroki H, Ikeya M

Nature Communications 12: 5012 doi: 10.1038/s41467-021-25328-6

Research publications

Transplantation of human autologous synovial mesenchymal stem cells with trisomy 7 into the knee joint and 5 years of follow-up

Mizuno M, Endo K, Katano H, Amano N, Nomura M, Yoshinori Hasegawa, Nobutake Ozeki, Hideyuki Koga, Takasu N, Osamu Ohara, Tomohiro Morio, Ichiro Sekiya

Stem Cells Translational Medicine doi :10.1002/sctm.20-0491

Research publications

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)

Hanatani T, Takasu N

Stem Cell Research Volume 50 102033 doi :10.1016/j.scr.2020.102033

Research publications

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease

Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K, Amano N, Nomura M, Umekage M, Morizane A, Takahashi J

PMID: 32632153 DOI : 10.1038/s41467-020-17165-w

Research publications

HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration

Sugita S, Mandai M, Hirami Y, Takagi S, Maeda T, Fujihara M, Matsuzaki M, Yamamoto M, Iseki K, Hayashi N, Hono A, Fujino S, Koide N, Sakai N, Shibata Y, Terada M, Nishida M, Dohi H, Nomura M, Amano N, Sakaguchi H, Hara C, Maruyama K, Daimon T, Igeta M, Oda T, Shirono U, Tozaki M, Totani K, Sugiyama S, Nishida K, Kurimoto Y, Takahashi M

J Clin Med 9(7): 2217 doi: 10.3390/jcm9072217

Research publications

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells

Ueda T , Kumagai A , Iriguchi S , Yasui Y , Miyasaka T , Nakagoshi K , Nakane K , Saito K , Takahashi M , Sasaki A , Yoshida S , Takasu N , Seno H , Uemura Y , Tamada K , Nakatsura T , Kaneko S

PMID: 32133731 doi: 10.1111/cas.14374

Research publications

Overview: an iPS cell stock at CiRA

Umekage M, Sato Y, Takasu N

Inflamm Regener 39: 17 doi: 10.1186/s41232-019-0106-0

Research publications

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility

Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A

Cell Stem Cell 24(4):566-578.e7 doi: 10.1016/j.stem

Research publications

Quality control guidelines for clinical-grade human induced pluripotent stem cell lines

Sullivan S, Stacey GN, Akazawa C, Aoyama N, Baptista R, Bedford P, Griscelli AB, Chandra A, Elwood N, Girard M, Kawamata S, Hanatani T, Latsis T, Lin S, Ludwig TE, Malygina T, Mack A, Mountford JC, Noggle S, Pereira L, Price J, Sheldon M, Srivastava A, Stachelscheid H, Velayudhan SR, Ward NJ, Turner ML, Barry J, Song J.

Regen Med 13:859 doi: 10.2217/rme-2018-0095

1 2 3